mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |